The type 1 insulin-like growth factor receptor pathway.
Research conducted over the past two decades has shown the importance of the type 1 insulin-like growth factor receptor (IGF1R) in tumorigenesis, metastasis, and resistance to existing forms of cancer therapy. The IGF1R itself has only recently been accepted as a credible treatment target, however,...
Hlavní autoři: | Chitnis, M, Yuen, J, Protheroe, A, Pollak, M, Macaulay, V |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2008
|
Podobné jednotky
-
Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells.
Autor: Aleksic, T, a další
Vydáno: (2010) -
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer.
Autor: Yuen, J, a další
Vydáno: (2009) -
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
Autor: Yuen, J, a další
Vydáno: (2009) -
Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer.
Autor: Yuen, J, a další
Vydáno: (2008) -
The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer.
Autor: Rochester, M, a další
Vydáno: (2007)